NASDAQ
IGC Pharma, Inc. (IGC) has a free cash flow growth of 0.89% as of Friday, May 29, 2026. This represents a 110.42% increase compared to its 12-month average of -8.55%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.